Answers are grounded in this paper and cite their sources.
Results obtained would guide further development of Atractylodes lancea (Thunb.) DC. as potential anti-CCA chemotherapeutics concerning the appropriate pharmaceutical dosage form.
No takes yet. Share an insight, caveat, or question.
Martviset et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: